SP-103

· Scilex Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SP-103, covering 2024-05-24 to 2026-07-06. Get the full timeline:

Most recent: Clinical Trial Results: Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain [Phase 2]